Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis-Reference-Cited by-同舟云学术

Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis

Published:2021-07-30 Issue:9 Volume:41 Page:921-924
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Zhou Chengjing¹,Jiang Ting¹,Li Rongzhen¹,Yuan Yan¹,Xie Weihao¹,Huang Xiaoxue¹,Wang Qiaoxuan¹,Chang Hui¹,Chen Gong²,Li Yuhong³,Zeng Zhifan¹,Xiao Weiwei¹^ORCID,Gao Yuanhong¹^ORCID

Affiliation:

1. Department of Radiation Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

2. Department of Colorectal Surgery State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

3. Department of Medical Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12199

Reference10 articles.

1. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

2. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer